# Incretin Effects of Branched Chain Amino Acids

> **NCT02697305** · NA · COMPLETED · sponsor: **Charles University, Czech Republic** · enrollment: 18 (actual)

## Conditions studied

- Glucose Metabolism Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** IV BCAA
- **DIETARY_SUPPLEMENT:** ORAL BCAA
- **OTHER:** ORAL Placebo

## Key facts

- **NCT ID:** NCT02697305
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-05
- **Final completion:** 2015-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02697305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02697305, "Incretin Effects of Branched Chain Amino Acids". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02697305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*